Renal effects and nephrotoxicity of contrast media in renal patients.
Donadio
C
C
Unità di Nefrologia, Clinica Medica 2, Università di Pisa, Italia.
Tramonti
G
G
Giordani
R
R
Lucchetti
A
A
Calderazzi
A
A
Ferrari
P
P
Bianchi
C
C
D000293:Adolescent; D000328:Adult; D000368:Aged; D003974:Diatrizoate Meglumine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007472:Iohexol / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D007479:Iopamidol / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D007674:Kidney Diseases / Q000139:chemically induced* / Q000503:physiopathology; D007684:Kidney Tubules / Q000187:drug effects*; D008297:Male; D008657:Metabolic Clearance Rate / Q000502:physiology; D008875:Middle Aged
D003974:Diatrizoate Meglumine; D007472:Iohexol; D007479:Iopamidol